Received May 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
tested positive for HPV at the age of 21; This spontaneous report was received from a nurse and refers to a 21-year-old patient of unknown gender. The patient's medical history, past medications and concomitant medications were not reported. On unknown dates, at the age of 14 years old, the patient was fully vaccinated with a two-dose schedule of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection (exact doses, routes of administration, anatomical locations, lot numbers and expiry dates were not reported), for prophylaxis. On an unspecifed date (reported as "recently"), the patient was tested positive for human papillomavirus (HPV). The outcome of the event was not provided. The action taken with the suspect vaccine regarding the event was considered as not applicable. The causality assessment between the event and human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) was not provided. The reporter considered the event of tested positive for human papillomavirus (HPV) to be non-serious.
Test Name: tested positive for HPV; Test Result: Positive